The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.

Published by Michael on

Related Posts

Medical

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

Front Pharmacol. 2022 May 10;13:885655. doi: 10.3389/fphar.2022.885655. eCollection 2022. ABSTRACT A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC prescribing by healthcare practitioners (HCPs) is Read more…

Medical

Predictors of Medical Students' Perceptions About Medical Cannabis

Cureus. 2022 Apr 22;14(4):e24390. doi: 10.7759/cureus.24390. eCollection 2022 Apr. ABSTRACT BACKGROUND: There has been a recent uptick in interest regarding the therapeutic properties of cannabis. Evidence exists to support the role of medical cannabis (MC) Read more…

Medical

Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context

Prev Med Rep. 2022 May 13;28:101822. doi: 10.1016/j.pmedr.2022.101822. eCollection 2022 Aug. ABSTRACT Differences in cannabis use patterns among racial, ethnic and sexual minoritized identity subgroups have been attributed to marginalized identity stressors. However, associations at Read more…

error: Content is protected !!